Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 125.99% | -83.26% | 84.80% | 52.49% | 6.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 125.99% | -83.26% | 84.80% | 52.49% | 6.23% |
| Operating Income | -125.99% | 83.26% | -84.80% | -52.49% | -6.23% |
| Income Before Tax | -75.41% | 69.80% | -65.39% | -798.90% | -0.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.41% | 69.80% | -65.39% | -798.90% | -0.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.41% | 69.80% | -65.39% | -798.90% | -0.74% |
| EBIT | -125.99% | 83.26% | -84.80% | -52.49% | -6.23% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 22.31% | 86.49% | 17.66% | -522.83% | 20.49% |
| Normalized Basic EPS | 22.70% | 91.98% | 17.61% | 6.01% | 20.49% |
| EPS Diluted | 22.31% | 86.49% | 17.66% | -522.83% | 20.49% |
| Normalized Diluted EPS | 22.70% | 91.98% | 17.61% | 6.01% | 20.49% |
| Average Basic Shares Outstanding | 126.05% | 123.98% | 100.88% | 44.30% | 26.88% |
| Average Diluted Shares Outstanding | 126.05% | 123.98% | 100.88% | 44.30% | 26.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
